Zoll warns on Q3 due to temporary production problem
This article was originally published in Clinica
Executive Summary
Zoll Medical has warned that its third-quarter earnings will not meet expectations. The Burlington, Massachusetts-based company, which makes a range of noninvasive resuscitation devices and disposable electrodes, said that preliminary third-quarter EPS would be $0.19-0.22, compared with consensus estimates of $0.28.